Background: Drug distribution to the eye is still tricky because of the eye's intricate structure. Systemic delivery, as opposed to more traditional methods like eye drops and ointments, is more effective but higher doses can be harmful.
Objective: The use of solid lipid nanoparticles (SLNPs) as a method of drug delivery has been the subject of research since the 1990s.